
Accretion Nutraveda
BSE SME₹2,58,000 / Individual : 2000 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 30 Jan 2026, 05:57 PM |
| QIBs | 1.01 times |
| NII | 2.42 times |
| Total | 1.91 times |
Accretion Nutraveda IPO Details
The Accretion Nutraveda IPO price band is set between ₹122-129 per equity share, with a face value of ₹10 per share. The issue is managed by Kfin Technologies Ltd., and the equity shares are proposed to be listed on the BSE SME.
The IPO date for subscription opens on 28 Jan, 2026 and closes on 30 Jan, 2026. Investors can check the allotment status on 2 Feb, 2026, while the listing date is tentatively scheduled for 4 Feb, 2026.
The total issue size is 19,20,000 shares, aggregating up to ₹24.77 crore. Stay tuned for the latest Accretion Nutraveda IPO review and GMP updates.
Accretion Nutraveda IPO Review, Rating & Analysis
Accretion Nutraveda IPO Review
NO REVIEWAccretion Nutraveda IPO Rating
Accretion Nutraveda IPO Highlights
IPO Date
Jan 28, 2026 - Jan 30, 2026
Listing Date
4 Feb, 2026
Face Value
₹10 Per Equity Share
Price Band
₹122-129 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE SME
Accretion Nutraveda IPO Lot Size
The minimum market lot for Accretion Nutraveda IPO is 2000 shares with an application amount of ₹2,58,000. Retail investors can apply for up to 0 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹2,58,000 |
| Retail (Max) | 0 | 0 | ₹0 |
| S-HNI (Min) | 1 | 2000 | ₹2,58,000 |
| S-HNI (Max) | 3 | 6000 | ₹7,74,000 |
| B-HNI (Min) | 4 | 8000 | ₹10,32,000 |
Accretion Nutraveda IPO Timeline
Issue Price
₹122-129 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE SMERegistrar
Kfin Technologies Ltd.Lead Manager
Sobhagya Capital Options Pvt.Ltd.Issue Size
19,20,000 shares(aggregating up to ₹24.77 crore)Accretion Nutraveda IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-25 | 10.86 | 16.06 | 2.61 | 5.35 | 4.86 | 3.86 |
| 31-Mar-24 | 4.64 | 5.20 | 0.82 | 1.08 | 0.72 | 2.17 |
| 31-Mar-23 | 4.06 | 3.07 | 0.28 | 0.26 | -0.10 | 1.97 |
In Cr.
Accretion Nutraveda IPO Reservation Details
| Investor Category | Shares Offered | % Shares |
|---|---|---|
| Anchor Investor Shares Offered | 544000 | 28.33% |
| Market Maker Shares Offered | 96000 | 5% |
| QIB Shares Offered | 364000 | 18.96% |
| NII (HNI) Shares Offered | 276000 | 14.38% |
| bNII > ₹10L | 184000 | 9.39% |
| sNII < ₹10L | 92000 | 4.85% |
| Individual Shares Offered | 640000 | 33.33% |
| Total Shares Offered | 1920000 | 100% |
Accretion Nutraveda IPO Documents
Accretion Nutraveda IPO Valuations
EPS Pre IPO
₹4.91/-EPS Post IPO
₹6.44/-PE Pre IPO
26.27PE Post IPO
20.02ROE
81.22%ROCE
36.98%Debt Equity
0.72RoNW
48.85%PAT Margin
16.33%Price to Book Value
8.76Promoters & Share Holding
Promoter(s) Name
- Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 100% | 73.48% |
About Company
Incorporated in the year 2021, Accretion Nutraveda is engaged in the manfacturing of Ayurvedic and nutraceutical products in different dosage forms, which include tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels.
The company is a Contract Development and Manufacturing Organization (CDMO) that caters to both local and international markets, including Sri Lanka, Singapore, and USA. It provides products that incorporate the wisdom of Ayurvedic science, along with the latest nutraceutical technology, to alleviate conditions such as liver care, women’s health, boneness and joint care, brain support, and respiratory health.
Business verticals:
Domestic Sales & Merchant Exports (Loan Licence Basis) - contributing 96.62% to total revenues in FY 2024-25.
Direct Exports– Contributing 38%, with a constant rise in It has a manufacturing plant in Gujarat which occupies around 10,763 sq. ft. and is well-equipped with latest infrastructure like 13 air handling units, processing areas, and quality control equipment. The plant is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified along with FSSAI license.
Accretion Nutraveda IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 3,64,000 | 2,76,000
1,84,000
92,000
| 6,40,000 | 12,80,000 |
Day 128-01-26 05:00 PM | 0.00 x | 0.45
x
0.57 x
0.23 x
| 0.21 x | 0.20 x |
Day 229-01-26 05:00 PM | 0.99 x | 0.99
x
1.00 x
0.98 x
| 0.43 x | 0.71 x |
Day 330-01-26 05:00 PM | 1.01 x | 2.42
x
2.47 x
2.33 x
| 2.19 x | 1.91 x |
Day 402-02-26 05:00 PM | 1.01 x | 2.42
x
2.47 x
2.33 x
| 2.19 x | 1.91 x |
Retail:2.19x
BHNI:0.74x
SHNI:2x
Accretion Nutraveda IPO - Issue Objectives & Utilisation of proceeds
| Objectives | Amount |
|---|---|
| Purchase of Machineries for Automation in existing Manufacturing unit | - |
| Purchase of Machineries for New Manufacturing Setup | - |
| Funding working capital requirements of our company | - |
| General corporate purposes | - |
Company Contact Details
Accretion Nutraveda
27 Xcelon Industrial Park-1 Vasna-Chacharwadi, Ta-Sanand, Ahmedabad, Gujarat, 382213Phone: +91 9904366177
Email: compliance@accretionnutraveda.com
Website: http://www.accretionnutraveda.com/
Registrar Contact Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: citichemindia.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Frequently Asked Questions about Accretion Nutraveda IPO
When will Accretion Nutraveda IPO open for subscription?
The Accretion Nutraveda IPO opens on 28 Jan, 2026 and closes on 30 Jan, 2026.
What is the investors portion for Accretion Nutraveda IPO?
The investors' portion for QIB is 1.01 x, NII is 2.47 x, and Retail is 2.19 x.
How to apply for Accretion Nutraveda IPO?
You can apply for Accretion Nutraveda IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Accretion Nutraveda IPO?
The issue size of Accretion Nutraveda IPO is approx ₹19,20,000 shares(aggregating up to ₹24.77 crore) crores.
What is the price band of Accretion Nutraveda IPO?
The price band for Accretion Nutraveda IPO is ₹122 to ₹129 per equity share.
What is the lot size of Accretion Nutraveda IPO?
The minimum bid (lot size) for Accretion Nutraveda IPO is 1000 shares with an investment of approx ₹2,58,000 .
What is the allotment date of Accretion Nutraveda IPO?
The allotment date for Accretion Nutraveda IPO is 2 Feb, 2026.
What is the listing date of Accretion Nutraveda IPO?
The listing date for Accretion Nutraveda IPO is expected to be 4 Feb, 2026.
What is the GMP of Accretion Nutraveda IPO?
The latest Grey Market Premium (GMP) for Accretion Nutraveda IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.
